Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Lydia Spencer-Elliott

Women’s health experts issue warning on limitations of ‘miracle’ endometriosis pill

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, which was approved for NHS use this week.

The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill licensed to treat endometriosis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.